Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DanDrit Biotech USA, Inc.
New York City, New York, United Statesdandrit.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
DanDrit Biotech was a biopharmaceutical company focused on developing dendritic cell-based immunotherapies for cancer. Its lead candidate MelCancerVac targeted the MAGE-A antigen family using autologous dendritic cells loaded with allogeneic tumor lysate. The company expanded its pipeline through acquisitions—including OncoSynergy’s anti-CD29 mAb OS2966 for glioblastoma/ovarian cancer and later Enochian’s HIV/AIDS gene therapy assets. After acquiring Enochian in February 2018, the combined entity rebranded as Enochian BioSciences and shifted focus to advanced gene/cell therapies for oncology and infectious diseases.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Dendritic cell-based immunotherapies/vaccinesMonoclonal antibodiesCell and gene therapiesAI-driven diagnostics and multiomics platforms
- Industry
- Biotech
02
Partnerships
University of California San Francisco (academic collaboration via OncoSynergy asset purchase)University of Strasbourg (academic collaboration via OncoSynergy asset purchase)Weird Science LLC (exclusive license for HIV technologies post-Enochian merger)
Beyond the preview
Go deeper on DanDrit Biotech USA, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DanDrit Biotech USA, Inc..